Translating Molecular Imaging of the Vulnerable Plaque-a Vulnerable Project?

被引：4

作者：

Bala, Gezim ^{[1
,2
]}

Broisat, Alexis ^{[3
]}

Lahoutte, Tony ^{[1
,4
]}

Hernot, Sophie ^{[1
]}

机构：

[1] Vrije Univ Brussel, Vivo Cellular & Mol Imaging ICMI BEFY, Brussels, Belgium

[2] UZ Brussel, Dept Cardiol, Brussels, Belgium

[3] 1039 Univ Grenoble, INSERM, Radiopharmaceut Bioclin, La Tronche, France

[4] UZ Brussel, Dept Nucl Med, Brussels, Belgium

来源：

MOLECULAR IMAGING AND BIOLOGY | 2018年 / 20卷 / 03期

关键词：

Atherosclerosis; Vulnerable plaque imaging; Translational medicine; Molecular imaging; HIGH-RISK PATIENTS; PCSK9; INHIBITORS; ATHEROSCLEROSIS; INFLAMMATION; RATIONALE; EVENTS; DESIGN; PET;

D O I：

10.1007/s11307-017-1147-x

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：337 / 339

页数：3

共 23 条

[1] Acute Coronary Events [J].

Arbab-Zadeh, Armin ;

Nakano, Masataka ;

Virmani, Renu ;

Fuster, Valentin .

CIRCULATION, 2012, 125 (09) :1147-1156

[2] Emerging anti-inflammatory drugs for atherosclerosis [J].

Berman, Jeremy P. ;

Farkouh, Michael E. ;

Rosenson, Robert S. .

EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (02) :193-205

[3] BIOCHEMISTRY TO BEHAVIOUR [J].

Cannon, Bill .

NATURE, 2013, 493 (7434) :S2-S3

[4] Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: A Pathologic study [J].

Cheruvu, Pavan K. ;

Finn, Aloke V. ;

Gardner, Craig ;

Caplan, Jay ;

Goldstein, James ;

Stone, Gregg W. ;

Virmani, Renu ;

Muller, James E. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (10) :940-949

[5] PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumab [J].

Dahagam, Chanukya ;

Goud, Aditya ;

Abdelqader, Abdelhai ;

Hendrani, Aditya ;

Feinstein, Matthew J. ;

Qamar, Arman ;

Joshi, Parag H. ;

Swiger, Kristopher J. ;

Byrne, Kathleen ;

Quispe, Renato ;

Jones, Steven R. ;

Blumenthal, Roger S. ;

Martin, Seth S. .

FUTURE CARDIOLOGY, 2016, 12 (02) :139-148

[6] PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumab [J].

Dahagam, Chanukya ;

Goud, Aditya ;

Abdelqader, Abdelhai ;

Hendrani, Aditya ;

Feinstein, Matthew J. ;

Qamar, Arman ;

Joshi, Parag H. ;

Swiger, Kristopher J. ;

Byrne, Kathleen ;

Quispe, Renato ;

Jones, Steven R. ;

Blumenthal, Roger S. ;

Martin, Seth S. .

FUTURE CARDIOLOGY, 2016, 12 (02) :149-157

[7] Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis [J].

Dweck, Marc R. ;

Aikawa, Elena ;

Newby, David E. ;

Tarkin, Jason M. ;

Rudd, James H. F. ;

Narula, Jagat ;

Fayad, Zahi A. .

CIRCULATION RESEARCH, 2016, 119 (02) :330-340

[8] Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis [J].

Everett, Brendan M. ;

Pradhan, Aruna D. ;

Solomon, Daniel H. ;

Paynter, Nina ;

MacFadyen, Jean ;

Zaharris, Elaine ;

Gupta, Milan ;

Clearfield, Michael ;

Libby, Peter ;

Hasan, Ahmed A. K. ;

Glynn, Robert J. ;

Ridker, Paul M. .

AMERICAN HEART JOURNAL, 2013, 166 (02) :199-+

[9] Concept of Vulnerable/Unstable Plaque [J].

Finn, Aloke V. ;

Nakano, Masataka ;

Narula, Jagat ;

Kolodgie, Frank D. ;

Virmani, Renu .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (07) :1282-1292

[10] 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial [J].

Joshi, Nikhil V. ;

Vesey, Alex T. ;

Williams, Michelle C. ;

Shah, Anoop S. V. ;

Calvert, Patrick A. ;

Craighead, Felicity H. M. ;

Yeoh, Su Ern ;

Wallace, William ;

Salter, Donald ;

Fletcher, Alison M. ;

van Beek, Edwin J. R. ;

Flapan, Andrew D. ;

Uren, Neal G. ;

Behan, Miles W. H. ;

Cruden, Nicholas L. M. ;

Mills, Nicholas L. ;

Fox, Keith A. A. ;

Rudd, James H. F. ;

Dweck, Marc R. ;

Newby, David E. .

LANCET, 2014, 383 (9918) :705-713

← 1 2 3 →